Schrödinger, Inc. (SDGR)
Upgrades & Downgrades
Latest SDGR news
7 Small-Cap Stock Picks to Beat the September Market Slump
15 September 2022
When compiling my small-cap stock picks, I tried to choose names that seemed to be benefiting from this new, more “risk-on” environment. Among the encouraging features of the August Consumer Price Ind...
Schrödinger: Q2 Earnings Supports Growth Narrative
26 August 2022
Schrödinger reported mixed Q2 earnings with a miss on EPS and a beat on revenue. The company experienced strong performance across both aspects of the company business. The company revealed another qu...
Schrodinger, Inc. (SDGR) CEO Ramy Farid on Q2 2022 Results - Earnings Call Transcript
4 August 2022
Schrodinger, Inc. (NASDAQ:SDGR ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Jaren Madden - SVP, IR & Corporate Communications Ramy Farid - CEO, President & Directo...
Schrodinger, Inc. (SDGR) Reports Q2 Loss, Tops Revenue Estimates
4 August 2022
Schrodinger, Inc. (SDGR) delivered earnings and revenue surprises of -1.64% and 2.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Schrödinger to Present at Jefferies Healthcare Conference
2 June 2022
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at the Jefferies Healthcare Conference.
Schrödinger to Present at Citi Biotech Virtual Co-Panel Day
13 May 2022
NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will present at Citi Biotech Virtual Co-Panel Day.
Schrödinger's (SDGR) CEO Ramy Farid on Q1 2022 Results - Earnings Call Transcript
4 May 2022
Schrödinger, Inc. (NASDAQ:SDGR ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Jaren Madden – Senior Vice President of Investor Relations and Corporate Affairs Ramy Fari...
3 Hypergrowth Tech Stocks to Buy for Huge Upside Potential
7 April 2022
These hypergrowth stocks are bargains after retreating for much of the last year. They will all perform very well for long-term investors.
Schrödinger: Holding The Keys To Discovery
25 March 2022
Schrödinger software platform makes it chiefly a healthcare technology company; however, the company is developing an impressive pipeline and list partners from their drug discovery efforts.